Viewing StudyNCT00116844



Ignite Creation Date: 2024-05-05 @ 11:42 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00116844
Status: COMPLETED
Last Update Posted: 2018-02-12
First Post: 2005-06-30

Brief Title: VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 HSV-2 Seropositive Subjects VALTREX Tablet is a Trademark of GlaxoSmithKline Group of Companies
Sponsor:
Organization: GlaxoSmithKline